shows the CSF findings in the 21 patients.
increased intracerebral production of immunoglobulin G expressed by the cerebrospinal fluid IgG index. At follow-up two to four years later, 13 of 16 patients (81 %) in whom both evoked potentials and IgG index were abnormal initially had entered into a higher multiple sclerosis diagnostic class. In the five patients in whom either evoked potentials or IgG index were normal the original diagnosis was unchanged.
In a previous report' we suggestedka reclassification of patients with suspected multiple sclerosis when electrophysiological and CSF findings were taken into consideration. If abnormality of visual and somatosensory evoked potentials added more to the diagnosis than history and clinical signs and if the CSF immunoglobulin G (IgG) was increased, the patient was grouped in a higher class. To test the validity of this reclassification, we have undertaken a follow-up of the patients classified on clinical grounds .as possible or probable cases of multiple sclerosis.
Material and methods
The patient group comprised 21 individuals ranging in age between 23 and 68 years (13 female, 8 male), who were considered to have probable (7 patients) and possible (14 patients) multiple sclerosis at the first examination according to previously published diagnostic criteria.2 In short, patients were classified as probable cases when they had had a single episode suggestive of multiple sclerosis and clinical evidence of lesions at two or more separate sites in the CNS (five patients), or a progressive history of paraplegia and clinical evidence of lesions at two or more separate sites in the CNS (two patients). Patients were classified as possible cases if they had had a progressive history of paraplegia and evidence of one lesion only (six patients), Accepted IgG index) showed no change in the clinical condition. The mean follow-up time for these five patients was 31 months (range 25-40). Table 4 shows the average latency of EPs at the first and final investigation in the 13 patients in whom the disease progressed compared to the eight in whom the clinical condition was unchanged. On average the VEP latency increased from 116 to 127 ms in patients with clinical deterioration, whereas it was 108 ms and 109 ms at the first and final examination respectively in the patients without clinical progression. Regarding the average mean latency of SEPs following median nerve stimulation, there was no difference between the two examinations in either of the two groups. The mean latency of the SEP to tibial nerve stimulation increased from 46 to 58 ms in the group with clinical progression whereas no difference was found in the clinical unchanged group. An increase in latency of either the VEP or SEP or both occurred in 10 of the patients with clinical exacerbations and in only one of the clinically unchanged patients. Table 5 shows the average mean latency of EPs in patients with and without a change in latency from the first to the final investigation related to the clinical condition at the final examination. When the difference in latency between the two determinations exceeded twice the SD or more it was considered a significant change. There was an increase in the average latencies of the VEP and SEPs in 10 of the 13 patients with clinical progression, whereas the mean latency of EPs was unchanged in the eight patients without progression. The latency of P100 of the VEP increased from 118 to 141 ms (p < 0.01) and the latency to onset of the SEPs following median and tibial nerve stimulation increased from 23 to 34 ms and from 49 to 73 ms respectively (p < 0-05 and p < 0.01) in patients showing clinical deterioration.
The individual values of EPs at the first and final investigation are plotted in figs 2 and 3. The latencies of VEPs and SEPs were pooled together if there was no significant change from the first to the final examination independent of the clinical findings. The average increase in latency of the VEPs that occurred in nine patients in whom the disease progressed was 22 + 2*3 ms (n = 22), of the SEPs following median nerve stimulation which occurred in four patients was 11.9 + 3-8 ms (n = 7).
Moreover, in seven patients there was an average increase in latency of 25 + 5*1 ms (n = 11) following tibial nerve stimulation.
In three patients with clinical progression the latency of evoked potentials following pattern reversal stimulation was shorter at the final than at the first examination (fig 2) Although an abnormal EP in multiple sclerosis patients usually remains delayed, normalisation of EP latency with clinical remission has been reported.9'-3 We did not observe any such change in our material. On the other hand in 11 of 21 patients there was an increase of the EP latency from the first to the final investigation. All but one of these 11 patients belonged to the group in whom the disease progressed. On the contrary in seven patients we found a shorter EP latency at the final investigation than at the first. Six of these patients had a progressive course and one did not. Thus changes in latency of EPs between the two investigations occurred in Bo#tcher, Trojaborg 18 patients; in three of these the latency of the VEP increased, whereas the latency of the SEP following either median or tibial nerve stimulation decreased.
On account of changes in EP latencies it was not possible to predict the course of the disease.
To our knowledge there is no follow-up study of suspected multiple sclerosis cases similar to the present investigation. Matthews et all4 examined 39 patients with a single acute episode resembling multiple sclerosis and found delayed VEP in only two, both of whom at follow-up entered into one of the diagnostic categories of multiple sclerosis. The fate of the other 37 patients remains unknown. In another series of 96 possible cases of whom 27 patients (28%) had an abnormal VEP, subsequent clinical development and the result of other investigative procedures were compatible with the original diagnostic classification?5 However, there was no information as to the follow-up period, and the authors stated that a longer observation time was necessary to evaluate the diagnostic significance of the findings. In this connection it is important to emphasise that in none of our three non-progressive multiple sclerosis cases who fulfilled our diagnostic criteria for a reclassification had the follow-up examination (including laboratory test to exclude metabolic disorders and CT scan or myelography when indicated) revealed any other structural pathology as a cause of their symptoms and signs.
The present results seem to justify a reclassification of suspected multiple sclerosis cases into a higher diagnostic class at the first consultation when EP techniques provide evidence of more lesions than clinical examination, and if the IgG index also is increased. 
